540222:BOM
Laurus Labs Ltd
₹ 2,059.00
arrow_upward
+1.93%(+39.00) 1D
10-р сарын 16, 15:59:49 (GMT+5:30) · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 540222...
Open
₹ 2,027.35
High
₹ 2,086.00
Low
₹ 2,027.35
Mkt. cap
1.11ИН
Avg. vol.
84.29 мян
Volume
103.13 мян
Dividend
0.10%
Quarterly dividend
₹ 0.50
Ex-dividend date
2026 оны 5-р сарын 8
P/E ratio
101.80
52-wk high
₹ 2,086.00
52-wk low
₹ 870.05
EPS
₹ 20.23
Shares outstanding
106.44 сая
No. of employees
7 мян
Open
₹ 2,027.35
High
₹ 2,086.00
Low
₹ 2,027.35
Mkt. cap
1.11ИН
Avg. vol.
84.29 мян
Volume
103.13 мян
Dividend
0.10%
Quarterly dividend
₹ 0.50
Ex-dividend date
2026 оны 5-р сарын 8
P/E ratio
101.80
52-wk high
₹ 2,086.00
52-wk low
₹ 870.05
EPS
₹ 20.23
Shares outstanding
106.44 сая
No. of employees
7 мян
News stories
From web sources and news partners
The Economic Times
·
8 цагийн өмнө
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
TipRanks
·
3 өдрийн өмнө
Laurus Labs schedules Q2 and H1 FY27 earnings call for October 29
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd
CEOSatyanarayana Chava
Employees7.06 мян
Founded2005
Headquarters-
SectorPharmaceutical industry
Websitelauruslabs.com